Relay Therapeutics Inc. (RLAY)
NASDAQ: RLAY
· Real-Time Price · USD
3.29
0.07 (2.17%)
At close: Jun 16, 2025, 3:59 PM
3.33
1.37%
After-hours: Jun 16, 2025, 06:21 PM EDT
2.17% (1D)
| Bid | 3.1 |
| Market Cap | 563.2M |
| Revenue (ttm) | 7.68M |
| Net Income (ttm) | -333.39M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -1.49 |
| Forward PE | -1.76 |
| Analyst | Buy |
| Ask | 3.55 |
| Volume | 939,509 |
| Avg. Volume (20D) | 2,352,633 |
| Open | 3.27 |
| Previous Close | 3.22 |
| Day's Range | 3.10 - 3.31 |
| 52-Week Range | 1.77 - 10.72 |
| Beta | 1.59 |
About RLAY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLAY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RLAY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.12%
Relay Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
6 months ago
+12.42%
Relay Therapeutics shares are trading higher after the company announced updated interim clinical data for RLY-2608.
